CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
300999 Yihai Kerry Arawana Holdings
- 31.79
- +0.75+2.42%
Market Closed Apr 30 15:00 CST
172.35BMarket Cap66.23P/E (TTM)
32.60High31.30Low116.25KlotVolume31.31Open31.04Pre Close373.29MTurnover2.14%Turnover Ratio68.96P/E (Static)5.42BShares42.4852wk High1.83P/B17.25BFloat Cap24.4752wk Low37.25Limit Up542.65MShs Float145.13Historical High24.83Limit Down4.19%Amplitude24.47Historical Low0.11Dividend TTM32.11Avg Price49.07KlotAsk0.35%Div YieldTTM100Lot Size61.76KlotBid
Yihai Kerry Arawana Holdings Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -27.05%48.7B | -10.78%52.91B | -27.96%48.22B | -32.81%47.36B | 15.21%66.76B | 50.26%59.3B | 20.06%66.94B | 39.34%70.49B | 11.16%57.94B | -9.98%39.46B |
| Transactional financial assets | 28.81%20.33B | -45.60%11.16B | 6.72%21.64B | 12.29%16.45B | 28.09%15.78B | 2.04%20.52B | 5.24%20.27B | 35.02%14.65B | 17.35%12.32B | 67.81%20.1B |
| Notes receivable and accounts receivable | 2.52%8.98B | -21.15%9.61B | -13.74%9.71B | 5.30%9.26B | 6.47%8.76B | 5.58%12.18B | 13.25%11.25B | -3.50%8.79B | 2.79%8.22B | 31.10%11.54B |
| -Notes receivable | 31.01%675.8M | 32.75%718.55M | -6.52%639.98M | -10.05%473.36M | 0.39%515.86M | 8.53%541.26M | 23.67%684.62M | --526.27M | --513.86M | --498.74M |
| -Accounts receivable | 0.73%8.3B | -23.65%8.89B | -14.21%9.07B | 6.28%8.78B | 6.87%8.24B | 5.45%11.64B | 12.64%10.57B | -9.28%8.27B | -3.63%7.71B | 25.43%11.04B |
| Other receivables (including interest and dividends) | 1.17%3.16B | 2.86%2.28B | -39.71%2.89B | -33.15%3.08B | 3.56%3.12B | -36.54%2.22B | 96.69%4.79B | 32.51%4.61B | -42.56%3.01B | -10.63%3.49B |
| -Other receivable | ---- | ---- | ---- | -33.15%3.08B | ---- | -36.54%2.22B | ---- | 32.76%4.61B | ---- | -10.63%3.49B |
| Advance payment | 1.27%3.57B | 12.22%3.22B | -29.59%4.2B | -21.85%4.2B | -16.52%3.53B | -34.90%2.87B | 17.07%5.97B | -29.82%5.37B | -20.82%4.23B | 3.67%4.41B |
| Inventories | 17.40%44.54B | 14.39%54.44B | 8.39%40.09B | 1.91%43.75B | -18.98%37.93B | -10.32%47.59B | 0.71%36.99B | 2.30%42.93B | 9.50%46.82B | 13.13%53.07B |
| Receivable financing | 28.68%819.21M | 77.17%742.28M | 251.34%846.96M | 55.78%589.41M | 1.28%636.62M | 50.85%418.96M | -14.87%241.07M | -49.14%378.37M | -11.35%628.57M | -64.96%277.73M |
| Non-current assets due within one year | --24.48M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 16.39%4.18B | 24.80%4.49B | 34.15%3.63B | 12.69%3.61B | 24.62%3.59B | 13.03%3.6B | 7.52%2.71B | 20.94%3.2B | -26.28%2.88B | -20.64%3.19B |
| Total current assets | -4.45%135.02B | -6.04%140.43B | -11.73%132.45B | -14.30%129.67B | 3.22%141.3B | 9.79%149.45B | 11.69%150.04B | 17.75%151.3B | 5.64%136.89B | 8.89%136.13B |
| Non Current assets | ||||||||||
| Other equity investment | -11.64%899.81M | -10.80%912.63M | -15.52%879.75M | 9.66%1.09B | 3.25%1.02B | 9.61%1.02B | 11.88%1.04B | 6.97%993.78M | 7.43%986.27M | -1.80%933.44M |
| Other non-current financial assets | --2.45B | --2.33B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment real estate | 59.76%2.83B | 23.76%2.18B | 228.71%1.95B | 218.28%1.89B | 208.11%1.77B | 207.07%1.76B | 172.78%593.65M | 173.14%593.65M | 108.03%574.71M | 135.96%574.71M |
| Long-term equity investment | -60.18%1.2B | -61.35%1.15B | -0.00%3B | 0.76%3B | 2.40%3.02B | 2.40%2.99B | 1.35%3B | 3.71%2.98B | 3.03%2.95B | 2.37%2.92B |
| Fixed assets | ---- | ---- | ---- | 11.56%41.6B | ---- | 11.71%40.36B | ---- | 13.26%37.29B | ---- | 12.22%36.13B |
| Constru in process | ---- | ---- | ---- | -4.90%10.27B | ---- | 6.35%10.31B | ---- | 14.93%10.8B | ---- | 35.21%9.69B |
| Productive biological assets | 95.48%61.6M | 0.55%36.34M | 199.23%22.63M | --27.07M | --31.51M | --36.14M | --7.56M | ---- | ---- | ---- |
| Intangible assets | -1.13%14.68B | -1.10%14.72B | -1.03%14.78B | 0.12%14.82B | 0.53%14.85B | 0.85%14.88B | 2.64%14.94B | 1.80%14.81B | 4.75%14.77B | 6.54%14.76B |
| Goodwill | 0.00%5.99B | 0.00%5.99B | 0.00%5.99B | 0.00%5.99B | 0.00%5.99B | 0.00%5.99B | 0.00%5.99B | 0.00%5.99B | 0.00%5.99B | 0.00%5.99B |
| Long deferred expense | 4.08%285.27M | -3.69%265.53M | -8.33%259M | 6.50%267.2M | 16.68%274.08M | 15.04%275.69M | 24.99%282.52M | 28.17%250.89M | 20.69%234.9M | 21.00%239.64M |
| Deferred tax assets | 3.57%1.84B | 10.93%1.73B | 20.46%1.94B | 18.03%1.87B | 21.04%1.78B | 22.28%1.56B | 16.10%1.61B | 44.86%1.59B | 49.58%1.47B | 80.30%1.28B |
| Usufruct assets | 3.28%229.78M | 13.34%232.02M | 8.59%222.47M | 0.83%215.72M | 0.75%222.49M | -2.24%204.71M | -4.36%204.86M | 0.25%213.95M | -3.38%220.83M | -9.42%209.39M |
| Other non current assets | -68.87%1.33B | -77.33%2.12B | -77.32%2.48B | -80.33%2.32B | -79.12%4.28B | -50.67%9.37B | -44.33%10.94B | -46.56%11.79B | -6.35%20.5B | 6.41%18.99B |
| Exceptional items of non current assets | ---- | ---- | ---- | ---- | 3.32%76.63M | 172.73%286.35M | 39.46%444.33M | 354.75%355.99M | 2,505.20%74.17M | --104.99M |
| Total non current assets | -0.82%84.12B | -4.96%84.63B | -5.14%84.19B | -4.88%83.37B | -10.47%84.82B | -3.01%89.05B | -2.49%88.74B | -3.17%87.65B | 7.67%94.74B | 11.66%91.82B |
| Total assets | -3.09%219.14B | -5.64%225.06B | -9.28%216.63B | -10.84%213.04B | -2.38%226.12B | 4.63%238.5B | 5.96%238.79B | 9.10%238.95B | 6.46%231.63B | 9.98%227.94B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -12.82%77.3B | -15.97%80.16B | -21.99%75.61B | -22.68%77.62B | -6.89%88.67B | 8.39%95.4B | 9.36%96.92B | 17.26%100.39B | 9.51%95.23B | 11.80%88.01B |
| Notes payable and accounts payable | 129.01%17.28B | 28.97%16.83B | 14.50%14.27B | -2.95%10.38B | -18.46%7.55B | 47.03%13.05B | 80.48%12.46B | 57.05%10.69B | 31.75%9.25B | 25.75%8.88B |
| -Notes payable | 302.70%10.86B | 192.38%11.95B | 74.45%9.17B | 15.50%4.57B | -0.63%2.7B | 46.11%4.09B | 173.68%5.26B | 134.27%3.96B | 69.60%2.71B | 78.95%2.8B |
| -Accounts payable | 32.35%6.42B | -45.53%4.88B | -29.25%5.1B | -13.80%5.8B | -25.86%4.85B | 47.46%8.96B | 44.56%7.2B | 31.55%6.73B | 20.58%6.54B | 10.62%6.08B |
| Contract liabilities | 14.58%1.62B | 11.61%3.33B | 18.01%2.65B | -30.06%1.5B | -34.54%1.41B | -31.49%2.98B | -20.73%2.25B | -9.67%2.15B | -14.56%2.15B | -7.23%4.35B |
| Salaries payable | -4.74%704.8M | 4.79%1.28B | -0.78%1.16B | 8.25%851.59M | 12.13%739.83M | 1.09%1.22B | 24.29%1.17B | -30.75%786.7M | 38.70%659.78M | -7.34%1.21B |
| Taxs payable | 134.32%1.43B | 113.18%1.15B | 4.02%781.89M | -12.04%456.65M | -25.45%610.21M | -7.71%541.61M | -14.03%751.68M | -44.07%519.15M | -20.57%818.52M | -0.34%586.86M |
| Other payable (including interest and dividends) | -6.76%4.38B | 13.26%5.32B | 3.86%4.92B | 15.56%4.78B | 15.75%4.7B | 8.76%4.7B | 9.15%4.74B | -9.71%4.14B | 8.01%4.06B | 3.54%4.32B |
| -Dividend payable | ---- | ---- | -34.06%15.22M | 234.86%34.66M | ---- | --4.86M | --23.09M | -97.64%10.35M | ---- | ---- |
| -Other payable | ---- | ---- | ---- | 15.01%4.75B | ---- | 8.65%4.69B | ---- | -0.39%4.13B | ---- | 4.26%4.32B |
| Non current liabilities due within one year | -80.65%2.99B | -13.36%8.52B | 29.88%10.19B | 44.58%11.32B | 417.69%15.43B | 259.55%9.83B | 175.44%7.84B | 403.09%7.83B | 286.58%2.98B | 12.22%2.73B |
| Other current liabilities | 243.35%5.65B | 7.38%1.79B | -9.74%1.79B | -26.48%1.53B | -28.03%1.64B | -67.73%1.67B | -72.03%1.98B | -53.58%2.08B | -51.71%2.28B | 78.60%5.17B |
| Total current liabilities | -7.60%111.99B | -8.30%119.17B | -12.99%112.3B | -16.29%108.93B | 2.80%121.2B | 11.57%129.96B | 11.58%129.07B | 19.82%130.13B | 8.72%117.9B | 13.09%116.49B |
| Current liabilities | ||||||||||
| Long term loan | -10.58%5.16B | -51.62%5.01B | -55.98%5.28B | -59.17%5.26B | -65.93%5.77B | -34.12%10.36B | -19.46%11.99B | -17.99%12.9B | 8.93%16.95B | 42.89%15.72B |
| Bonds payable | --503.55M | --500.61M | ---- | ---- | ---- | ---- | 0.07%512.64M | 0.07%508.56M | 0.07%504.56M | 0.07%500.64M |
| Estimate liabilities | 1,033.51%6.5M | 1,033.51%6.5M | -9.18%2.64M | -9.18%2.64M | -90.92%573K | -90.92%573K | -38.40%2.91M | -89.56%2.91M | -75.89%6.31M | -75.89%6.31M |
| Deferred tax liabilities | -23.73%790.79M | -11.21%829.42M | -17.91%765.6M | 29.49%886.71M | 36.26%1.04B | 28.05%934.14M | 40.60%932.61M | 21.33%684.75M | 96.17%760.87M | 67.00%729.51M |
| Long term deferred income | -8.37%1.12B | -3.37%1.13B | 20.78%1.21B | 38.99%1.22B | 38.24%1.22B | 36.20%1.17B | 32.23%1.01B | 22.91%878.51M | 39.36%881.21M | 35.56%855.61M |
| Lease liabilities | -8.02%119.22M | 6.34%120.06M | 5.88%112.72M | 0.06%114.48M | 4.10%129.62M | -2.22%112.91M | -3.71%106.46M | 12.37%114.41M | -5.33%124.51M | -15.05%115.48M |
| Other non current liabilities | 371.89%94.29M | 3,088.48%94.35M | 585.77%94.25M | 418.53%82.42M | -79.84%19.98M | -97.64%2.96M | -88.94%13.74M | -87.37%15.9M | -18.65%99.13M | 15.72%125.42M |
| Exceptional items of non current liabilities | ---- | ---- | ---- | ---- | -99.70%412K | -97.96%2.42M | -29.26%22.51M | -91.21%14.71M | -74.72%137.26M | -60.15%118.58M |
| Total non current liabilities | -4.71%7.79B | -38.87%7.69B | -48.80%7.47B | -49.90%7.57B | -57.97%8.18B | -30.80%12.58B | -14.67%14.59B | -15.72%15.11B | 8.69%19.46B | 38.32%18.17B |
| Total liabilities | -7.42%119.78B | -11.00%126.85B | -16.63%119.77B | -19.79%116.5B | -5.81%129.38B | 5.85%142.54B | 8.20%143.65B | 14.78%145.24B | 8.71%137.36B | 15.94%134.66B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%5.42B | 0.00%5.42B | 0.00%5.42B | 0.00%5.42B | 0.00%5.42B | 0.00%5.42B | 0.00%5.42B | 0.00%5.42B | 0.00%5.42B | 0.00%5.42B |
| Capital reserve funds | 0.61%36.9B | 0.48%36.84B | 0.12%36.79B | 0.04%36.73B | -0.09%36.67B | -0.05%36.66B | 0.28%36.75B | 0.29%36.72B | 0.31%36.71B | 0.23%36.68B |
| Surplus reserve funds | 7.61%2.71B | 7.61%2.71B | 18.01%2.52B | 18.01%2.52B | 18.01%2.52B | 18.01%2.52B | 8.40%2.13B | 8.40%2.13B | 8.40%2.13B | 8.40%2.13B |
| Retained profit | 3.80%49.34B | 3.66%48.36B | 2.51%47.48B | 4.41%47.15B | 4.56%47.53B | 4.59%46.65B | 5.00%46.32B | 3.24%45.15B | 7.49%45.46B | 5.76%44.61B |
| Other composite income | 89.78%410.18M | 67.88%405.8M | 71.68%233.12M | 884.85%375.27M | 326.65%216.14M | 278.67%241.73M | 256.33%135.79M | -141.51%-47.81M | -88.02%50.66M | -125.29%-135.29M |
| Shareholders equity without minority interests | 2.62%94.78B | 2.45%93.74B | 1.86%92.45B | 3.15%92.19B | 2.88%92.36B | 3.14%91.5B | 3.06%90.76B | 1.74%89.38B | 3.55%89.78B | 2.31%88.71B |
| Minority interests | 4.55%4.58B | -0.00%4.47B | 0.98%4.42B | 0.35%4.35B | -2.48%4.38B | -2.34%4.47B | -3.08%4.38B | -6.32%4.33B | -0.77%4.49B | 3.83%4.58B |
| Total shareholder equity | 2.70%99.36B | 2.33%98.21B | 1.82%96.86B | 3.02%96.54B | 2.63%96.74B | 2.87%95.96B | 2.76%95.13B | 1.34%93.71B | 3.33%94.27B | 2.39%93.28B |
| Total liabilityies and equity | -3.09%219.14B | -5.64%225.06B | -9.28%216.63B | -10.84%213.04B | -2.38%226.12B | 4.63%238.5B | 5.96%238.79B | 9.10%238.95B | 6.46%231.63B | 9.98%227.94B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.